Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation

Abroad (travel likely)RecruitingPHASE4

Conditions

Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France
Contact: Study coordinator (Cécile RENARD, MD, PhD) · cecile.renard@ihope.fr · 0469166570
Contact: Principal Investigator (Cécile RENARD, MD, PhD)
Centre Hospitalier Lyon Sud, Pierre-Bénite, France
Contact: Study coordinator (Marie BALSAT, MD, PhD) · marie.balsat@chu-lyon.fr · 0478862240
Contact: Study coordinator (Hélène LABUSSIERE-WALLET, MD, PhD) · helene.labussiere-wallet@chu-lyon.fr · 0478862240
Contact: Principal Investigator (Marie BALSAT, MD, PhD)
Hélène LABUSSIERE-WALLET, MD, PhD (Sub-investigator)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy

Thrombotic Microangiopathies · Hematopoietic Stem Cell Transplantation

Abroad (travel likely)Recruiting

Tianjin, China

Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients

Thrombotic Microangiopathy

Abroad (travel likely)Recruiting

Buenos Aires, Argentina